Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2003;41:528-533
Published online before print February 24, 2003, doi: 10.1161/01.HYP.0000056997.40992.41
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
41/3/528    most recent
01.HYP.0000056997.40992.41v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Felmeden, D. C.
Right arrow Articles by Lip, G. Y.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Felmeden, D. C.
Right arrow Articles by Lip, G. Y.H.
Related Collections
Right arrow Lipids
Right arrow Thrombosis risk factors
Right arrow Clinical Studies
Right arrow Lipid and lipoprotein metabolism
Right arrow Other Vascular biology

(Hypertension. 2003;41:528.)
© 2003 American Heart Association, Inc.


Scientific Contributions

Low-Density Lipoprotein Subfractions and Cardiovascular Risk in Hypertension

Relationship to Endothelial Dysfunction and Effects of Treatment*

Dirk C. Felmeden; Charles G.C. Spencer; Andrew D. Blann; D. Gareth Beevers; Gregory Y.H. Lip

From the Haemostasis, Thrombosis, and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, UK.

Correspondence to Prof G.Y.H. Lip, Haemostasis, Thrombosis, and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham B18 7QH, UK. E-mail g.y.h.lip{at}bham.ac.uk

Although hypertensive patients are at particular risk of vascular complications, the possible contribution of an atherogenic lipoprotein profile and endothelial dysfunction to this risk is unclear. We investigated this by measuring LDL subfractions and flow-mediated dilation (FMD) (reflecting endothelial dysfunction) in a cohort of high-risk hypertensive patients. We studied 84 hypertensive patients (74 men; mean age, 64 years; SD 8). Chylomicron-free LDL subfractions were analyzed by disc polyacrylamide gel electrophoresis, producing an LDL score, with higher scores being equivalent to a greater proportion of the more atherogenic LDL subfractions. High-resolution ultrasound was used to assess endothelium-dependent brachial artery FMD after reactive hyperemia after vessel occlusion. Baseline levels were compared with 61 age- and gender-matched healthy normotensive control subjects. Mean LDL score was higher and FMD impaired in hypertensive subjects compared with control subjects. These indexes were significantly improved after 6 months of cardiovascular risk factor management. LDL score correlated significantly with the 10-year Framingham coronary heart disease risk score, with a negative correlation with FMD (both P<0.001). Abnormal atherogenesis and endothelial dysfunction are both present in hypertension and appear to be related to each other, potentially leading to vascular complications. The abnormal LDL scores also correlate with the 10-year cardiovascular risk and can be positively influenced by cardiovascular risk management.


Key Words: endothelium • flow-mediated dilatation • LDL subfractions




This article has been cited by other articles:


Home page
HypertensionHome page
E. M. Urbina, R. V. Williams, B. S. Alpert, R. T. Collins, S. R. Daniels, L. Hayman, M. Jacobson, L. Mahoney, M. Mietus-Snyder, A. Rocchini, et al.
Noninvasive Assessment of Subclinical Atherosclerosis in Children and Adolescents: Recommendations for Standard Assessment for Clinical Research: A Scientific Statement From the American Heart Association
Hypertension, November 1, 2009; 54(5): 919 - 950.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. A. Black, N. T. Cable, D. H.J. Thijssen, and D. J. Green
Importance of Measuring the Time Course of Flow-Mediated Dilatation in Humans
Hypertension, February 1, 2008; 51(2): 203 - 210.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
R. Migliacci, C. Becattini, R. Pesavento, G. Davi, M. C. Vedovati, G. Guglielmini, E. Falcinelli, G. Ciabattoni, F. Dalla Valle, P. Prandoni, et al.
Endothelial dysfunction in patients with spontaneous venous thromboembolism
Haematologica, June 1, 2007; 92(6): 812 - 818.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. Rodriguez-Porcel, J. Herrman, A. R. Chade, J. D. Krier, J. F. Breen, A. Lerman, and L. O. Lerman
Long-Term Antioxidant Intervention Improves Myocardial Microvascular Function in Experimental Hypertension
Hypertension, February 1, 2004; 43(2): 493 - 498.
[Abstract] [Full Text] [PDF]